|
2007
|
HA 14-1
|
Bcl-2 inhibitor and apoptosis inducer of tumor cells |
€75.00 |
|
2390
|
HAMNO
|
Novel protein interaction inhibitor of replication protein A (RPA) |
€85.00 |
|
1645
|
HDAC6 inhibitor ISOX
|
HDAC6 Inhibitor |
€105.00 |
|
2096
|
Hesperadin
|
Reversible and ATP-competitive inhibitor of Aurora B |
€95.00 |
|
1948
|
HIF Phd Inhibitor 4
|
Inhibitor of Hypoxia Inducible Factor PHD |
€110.00 |
|
2034
|
HIF-2 inhibitor 2
|
Allosteric inhibitor of HIF-2 |
€95.00 |
|
2614
|
HIF-2a Translation Inhibitor 76
|
HIF-2a translation inhibitor that works independent of mTOR |
€70.00 |
|
2021
|
HL 010183
|
Metformin derivative; AMPK activator |
€135.00 |
|
1643
|
HLI 373
|
HDM2 inhibitor |
€95.00 |
|
1616
|
HMR 1031
|
VLA-4 antagonist |
€105.00 |
|
1757
|
HMR 1098
|
K+ channel blocker (SUR1/Kir6.2 selective) |
€115.00 |
|
1687
|
Homocamptothecin, (±)-E-
|
Potent topoisomerase I (Topo 1) inhibitor |
€135.00 |
|
1890
|
HSF1A
|
Human HSF1 activator |
€125.00 |
|
2101
|
HSF1B
|
Human HSF1 activator |
€125.00 |
|
1650
|
HTI 286
|
Tubulin polymerization inhibitor |
€135.00 |